We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Antibody patenting without antibodies: a global trend.
- Authors
Hashimoto, Kazunori; Aida, Tomomi
- Abstract
This article discusses intellectual property regulations in cases where the applicants present the genetic engineering of an antibody as a subsidiary claim to an application to patent a human gene without demonstrating experimental antibody production. A statement of the Trilateral Patent Office, a joint effort of the European Union, Japan, and the U.S. that administers claims regarding intellectual property, indicating the acceptability of antibody claims is noted. A content analysis indicates how many patent claims in Japan present the development of antibodies without noting their experimental production. The use of this practice, which is also called the patenting of imaginary antibodies, is criticized as an attempt to prevent joint tenancy among biotechnology research companies.
- Subjects
IMMUNOGLOBULINS; PATENTS; JOINT tenancy; PATENTS (International law); GENETIC engineering research; BIOTECHNOLOGY industry research; INTELLECTUAL property -- International cooperation
- Publication
Nature Biotechnology, 2008, Vol 26, Issue 12, p1341
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt1208-1341